These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23206756)

  • 1. Artificial biosynthesis of phenylpropanoic acids in a tyrosine overproducing Escherichia coli strain.
    Kang SY; Choi O; Lee JK; Hwang BY; Uhm TB; Hong YS
    Microb Cell Fact; 2012 Dec; 11():153. PubMed ID: 23206756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of caffeic acid in Escherichia coli using its endogenous hydroxylase complex.
    Lin Y; Yan Y
    Microb Cell Fact; 2012 Apr; 11():42. PubMed ID: 22475509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous production of caffeic acid from tyrosine in Escherichia coli.
    Rodrigues JL; Araújo RG; Prather KL; Kluskens LD; Rodrigues LR
    Enzyme Microb Technol; 2015 Apr; 71():36-44. PubMed ID: 25765308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of plant-specific stilbene polyketides in metabolically engineered Escherichia coli.
    Watts KT; Lee PC; Schmidt-Dannert C
    BMC Biotechnol; 2006 Mar; 6():22. PubMed ID: 16551366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeic acid production enhancement by engineering a phenylalanine over-producing Escherichia coli strain.
    Huang Q; Lin Y; Yan Y
    Biotechnol Bioeng; 2013 Dec; 110(12):3188-96. PubMed ID: 23801069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of curcuminoids from tyrosine by a metabolically engineered Escherichia coli using caffeic acid as an intermediate.
    Rodrigues JL; Araújo RG; Prather KL; Kluskens LD; Rodrigues LR
    Biotechnol J; 2015 Apr; 10(4):599-609. PubMed ID: 25641677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of plant-specific phenylpropanoids by construction of an artificial biosynthetic pathway in Escherichia coli.
    Choi O; Wu CZ; Kang SY; Ahn JS; Uhm TB; Hong YS
    J Ind Microbiol Biotechnol; 2011 Oct; 38(10):1657-65. PubMed ID: 21424580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering E. coli for caffeic acid biosynthesis from renewable sugars.
    Zhang H; Stephanopoulos G
    Appl Microbiol Biotechnol; 2013 Apr; 97(8):3333-41. PubMed ID: 23179615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate modular metabolic engineering of Escherichia coli to produce resveratrol from L-tyrosine.
    Wu J; Liu P; Fan Y; Bao H; Du G; Zhou J; Chen J
    J Biotechnol; 2013 Sep; 167(4):404-11. PubMed ID: 23916948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial de novo biosynthesis of hydroxystyrene derivatives in a tyrosine overproducing Escherichia coli strain.
    Kang SY; Choi O; Lee JK; Ahn JO; Ahn JS; Hwang BY; Hong YS
    Microb Cell Fact; 2015 Jun; 14():78. PubMed ID: 26055892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial production of O-methylated flavanones from methylated phenylpropanoic acids in engineered Escherichia coli.
    Cui H; Song MC; Lee JY; Yoon YJ
    J Ind Microbiol Biotechnol; 2019 Dec; 46(12):1707-1713. PubMed ID: 31595455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo resveratrol production through modular engineering of an Escherichia coli-Saccharomyces cerevisiae co-culture.
    Yuan SF; Yi X; Johnston TG; Alper HS
    Microb Cell Fact; 2020 Jul; 19(1):143. PubMed ID: 32664999
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Li Y; Mao J; Liu Q; Song X; Wu Y; Cai M; Xu H; Qiao M
    ACS Synth Biol; 2020 Apr; 9(4):756-765. PubMed ID: 32155331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial synthesis of N-hydroxycinnamoyl phenethylamines and tyramines.
    Sim GY; Yang SM; Kim BG; Ahn JH
    Microb Cell Fact; 2015 Oct; 14():162. PubMed ID: 26463041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a chimeric biosynthetic pathway for the de novo biosynthesis of rosmarinic acid in Escherichia coli.
    Bloch SE; Schmidt-Dannert C
    Chembiochem; 2014 Nov; 15(16):2393-401. PubMed ID: 25205019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Step-by-step optimization of a heterologous pathway for de novo naringenin production in Escherichia coli.
    Gomes D; Rodrigues JL; Rodrigues LR
    Appl Microbiol Biotechnol; 2024 Aug; 108(1):435. PubMed ID: 39126431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo biosynthesis of p-coumaric acid and caffeic acid from carboxymethyl-cellulose by microbial co-culture strategy.
    Cai M; Liu J; Song X; Qi H; Li Y; Wu Z; Xu H; Qiao M
    Microb Cell Fact; 2022 May; 21(1):81. PubMed ID: 35538542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous caffeic acid biosynthesis in Escherichia coli is affected by choice of tyrosine ammonia lyase and redox partners for bacterial Cytochrome P450.
    Haslinger K; Prather KLJ
    Microb Cell Fact; 2020 Feb; 19(1):26. PubMed ID: 32046741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological synthesis of coumarins in Escherichia coli.
    Yang SM; Shim GY; Kim BG; Ahn JH
    Microb Cell Fact; 2015 May; 14():65. PubMed ID: 25927349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of artificially fused bifunctional enzyme 4CL1-CCR: a method for production of secreted 4-hydroxycinnamaldehydes in Escherichia coli.
    Liu S; Qi Q; Chao N; Hou J; Rao G; Xie J; Lu H; Jiang X; Gai Y
    Microb Cell Fact; 2015 Aug; 14():118. PubMed ID: 26264710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.